{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T06:52:43Z","timestamp":1782456763568,"version":"3.54.5"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004901","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de Minas Gerais","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004901","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Global Antimicrobial Resistance"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.jgar.2018.04.012","type":"journal-article","created":{"date-parts":[[2018,4,30]],"date-time":"2018-04-30T08:36:22Z","timestamp":1525077382000},"page":"287-293","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["In vivo and in vitro activity of a bis-arylidenecyclo-alkanone against fluconazole-susceptible and -resistant isolates of Candida albicans"],"prefix":"10.1016","volume":"14","author":[{"given":"N\u00edvea Pereira","family":"de S\u00e1","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00eddia F\u00e1tima Jos\u00e9","family":"de Paula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larissa Ferreira Finamore","family":"Lopes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lana Ivone Barreto","family":"Cruz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thelma Tirone Silv\u00e9rio","family":"Matos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cleudiomar In\u00e1cio","family":"Lino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renata Barbosa","family":"de Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine Maria","family":"de Souza-Fagundes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beth Burgwyn","family":"Fuchs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleftherios","family":"Mylonakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8068-1720","authenticated-orcid":false,"given":"Susana","family":"Johann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jgar.2018.04.012_bib0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/10408410903241444","article-title":"Epidemiology of invasive mycoses in North America","volume":"36","author":"Pfaller","year":"2010","journal-title":"Crit Rev Microbiol"},{"issue":"Suppl. 6","key":"10.1016\/j.jgar.2018.04.012_bib0010","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/1469-0691.12539","article-title":"Global trends in the distribution of Candida species causing candidemia","volume":"20","author":"Guinea","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jgar.2018.04.012_bib0015","doi-asserted-by":"crossref","first-page":"e954","DOI":"10.1016\/j.ijid.2010.04.006","article-title":"Relative frequency of albicans and the various non-albicans Candida spp. among candidemia isolates from inpatients in various parts of the world: a systematic review","volume":"14","author":"Falagas","year":"2010","journal-title":"Int J Infect Dis"},{"issue":"Suppl. 1","key":"10.1016\/j.jgar.2018.04.012_bib0020","doi-asserted-by":"crossref","first-page":"i4","DOI":"10.1093\/jac\/dkx444","article-title":"Changes in the epidemiological landscape of invasive candidiasis","volume":"73","author":"Lamoth","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jgar.2018.04.012_bib0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jmii.2017.07.006","article-title":"2016 guidelines for the use of antifungal agents in patients with invasive fungal diseases in Taiwan","volume":"51","author":"Kung","year":"2018","journal-title":"J Microbiol Immunol Infect"},{"issue":"Suppl. 7","key":"10.1016\/j.jgar.2018.04.012_bib0030","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/1469-0691.12039","article-title":"ESCMID guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients","volume":"18","author":"Cornely","year":"2012","journal-title":"Clin Microbiol Infect"},{"issue":"Suppl. 7","key":"10.1016\/j.jgar.2018.04.012_bib0035","first-page":"53","article-title":"ESCMID* guideline for the diagnosis and management of Candida diseases 2012: adults with haematological malignancies and after haematopoietic stem cell transplantation (HCT)","volume":"18","author":"Ullmann","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jgar.2018.04.012_bib0040","article-title":"In vitro activities of novel azole compounds ATTAF-1 and ATTAF-2 against fluconazole-susceptible and -resistant isolates of Candida species","volume":"61","author":"Fakhim","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2018.04.012_bib0045","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/lam.12820","article-title":"Antifungals discovery: an insight into new strategies to combat antifungal resistance","volume":"66","author":"Fuentefria","year":"2018","journal-title":"Lett Appl Microbiol"},{"key":"10.1016\/j.jgar.2018.04.012_bib0050","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.ejmech.2013.11.011","article-title":"Synthesis and evaluation of the antiparasitic activity of bis-(arylmethylidene) cycloalkanones","volume":"71","author":"Braga","year":"2014","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.jgar.2018.04.012_bib0055","series-title":"Reference method for broth dilution antifungal susceptibility testing of yeasts; approved standard\u2014third edition. Document M27-A3","author":"Clinical and Laboratory Standards Institute","year":"2008"},{"key":"10.1016\/j.jgar.2018.04.012_bib0060","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1080\/00362177585190271","article-title":"An amino acid liquid synthetic medium for the development of mycelial and yeast forms of Candida albicans","volume":"13","author":"Lee","year":"1975","journal-title":"Sabouraudia"},{"key":"10.1016\/j.jgar.2018.04.012_bib0065","doi-asserted-by":"crossref","DOI":"10.1371\/annotation\/7b97b9ec-881a-4940-83ab-01f5318fd819","article-title":"Hyphal development in Candida albicans requires two temporally linked changes in promoter chromatin for initiation and maintenance","volume":"9","author":"Lu","year":"2011","journal-title":"PLoS Biol"},{"key":"10.1016\/j.jgar.2018.04.012_bib0070","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.ejmech.2015.07.032","article-title":"Thiazole compounds with activity against Cryptococcus gattii and Cryptococcus neoformans in vitro","volume":"102","author":"Pereira de S\u00e1","year":"2015","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.jgar.2018.04.012_bib0075","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02700-16","article-title":"Heterocycle thiazole compounds exhibit antifungal activity through increase in the production of reactive oxygen species in the Cryptococcus neoformans\u2013Cryptococcus gattii species complex","volume":"61","author":"S\u00e1","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2018.04.012_bib0080","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1371\/journal.ppat.0030018","article-title":"Antifungal chemical compounds identified using a C. elegans pathogenicity assay","volume":"3","author":"Breger","year":"2007","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.jgar.2018.04.012_bib0085","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0060047","article-title":"Antifungal efficacy during Candida krusei infection in non-conventional models correlates with the yeast in vitro susceptibility profile","volume":"8","author":"Scorzoni","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jgar.2018.04.012_bib0090","article-title":"In vitro and in vivo activity of a novel antifungal small molecule against Candida infections","volume":"9","author":"Wong","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jgar.2018.04.012_bib0095","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/lam.12086","article-title":"Hydroxyaldimines as potent in vitro anticryptococcal agents","volume":"57","author":"Magalh\u00e3es","year":"2013","journal-title":"Lett Appl Microbiol"},{"key":"10.1016\/j.jgar.2018.04.012_bib0100","doi-asserted-by":"crossref","first-page":"709","DOI":"10.7164\/antibiotics.50.709","article-title":"N-Methyl-N-d-fructopyranosylamphotericin B methyl ester, new amphotericin B derivative of low toxicity","volume":"50","author":"Grzybowska","year":"1997","journal-title":"J Antibiot (Tokyo)"},{"key":"10.1016\/j.jgar.2018.04.012_bib0105","doi-asserted-by":"crossref","first-page":"733","DOI":"10.2174\/092986711794480113","article-title":"New lead structures in antifungal drug discovery","volume":"18","author":"Sheng","year":"2011","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.jgar.2018.04.012_bib0110","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1007\/s40265-013-0069-4","article-title":"Amphotericin B formulations: a comparative review of efficacy and toxicity","volume":"73","author":"Hamill","year":"2013","journal-title":"Drugs"},{"key":"10.1016\/j.jgar.2018.04.012_bib0115","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1080\/21505594.2016.1197444","article-title":"Targeting Candida albicans filamentation for antifungal drug development","volume":"8","author":"Vila","year":"2017","journal-title":"Virulence"},{"key":"10.1016\/j.jgar.2018.04.012_bib0120","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/nrmicro2636","article-title":"Growth of Candida albicans hyphae","volume":"16","author":"Sudbery","year":"2011","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.jgar.2018.04.012_bib0125","doi-asserted-by":"crossref","first-page":"48988","DOI":"10.1074\/jbc.M104484200","article-title":"DNA array studies demonstrate convergent regulation of virulence factors by Cph1, Cph2, and Efg1 in Candida albicans","volume":"276","author":"Lane","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jgar.2018.04.012_bib0130","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/S1369-5274(03)00081-X","article-title":"Adaptation of Candida albicans to the host environment: the role of morphogenesis in virulence and survival in mammalian hosts","volume":"6","author":"Romani","year":"2003","journal-title":"Curr Opin Microbiol"},{"key":"10.1016\/j.jgar.2018.04.012_bib0135","article-title":"The role of Candida albicans SPT20 in filamentation, biofilm formation and pathogenesis","volume":"9","author":"Tan","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jgar.2018.04.012_bib0140","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1080\/21505594.2015.1012981","article-title":"Candida albicans\u2013epithelial interactions and pathogenicity mechanisms: scratching the surface","volume":"6","author":"Moyes","year":"2015","journal-title":"Virulence"},{"key":"10.1016\/j.jgar.2018.04.012_bib0145","doi-asserted-by":"crossref","first-page":"667","DOI":"10.6026\/97320630010667","article-title":"Anti-fungal resistance in Candida isolated from oral and diaper rash candidiasis in neonates","volume":"10","author":"Mohamadi","year":"2014","journal-title":"Bioinformation"},{"key":"10.1016\/j.jgar.2018.04.012_bib0150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1574-6968.2011.02262.x","article-title":"The contribution of mouse models to our understanding of systemic candidiasis","volume":"320","author":"Szabo","year":"2011","journal-title":"FEMS Microbiol Lett"},{"key":"10.1016\/j.jgar.2018.04.012_bib0155","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005952","article-title":"The Kallikrein\u2013Kinin system: a novel mediator of IL-17-driven anti-Candida immunity in the kidney","volume":"12","author":"Ramani","year":"2016","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.jgar.2018.04.012_bib0160","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1574-6968.2010.02170.x","article-title":"Comparison between efficacy of allicin and fluconazole against Candida albicans in vitro and in a systemic candidiasis mouse model","volume":"315","author":"Khodavandi","year":"2011","journal-title":"FEMS Microbiol Lett"}],"container-title":["Journal of Global Antimicrobial Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716518300791?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716518300791?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T09:52:59Z","timestamp":1761990779000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213716518300791"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":32,"alternative-id":["S2213716518300791"],"URL":"https:\/\/doi.org\/10.1016\/j.jgar.2018.04.012","relation":{},"ISSN":["2213-7165"],"issn-type":[{"value":"2213-7165","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In vivo and in vitro activity of a bis-arylidenecyclo-alkanone against fluconazole-susceptible and -resistant isolates of Candida albicans","name":"articletitle","label":"Article Title"},{"value":"Journal of Global Antimicrobial Resistance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jgar.2018.04.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier Ltd on behalf of International Society for Chemotherapy of Infection and Cancer.","name":"copyright","label":"Copyright"}]}}